Featured Research

from universities, journals, and other organizations

Study could help battle against superbugs

Date:
October 14, 2011
Source:
University of Edinburgh
Summary:
Targeting a toxin released by virtually all strains of MRSA could help scientists develop new drugs that can fight the superbug, research suggests. A new study has discovered the toxin -- SElX -- which leads the body's immune system to go into overdrive and damage healthy cells.

Targeting a toxin released by virtually all strains of MRSA could help scientists develop new drugs that can fight the superbug, research suggests.

Related Articles


A study led by the University of Edinburgh has discovered the toxin -- SElX -- which leads the body's immune system to go into overdrive and damage healthy cells.

The toxin SElX is made by 95 per cent of Staphylococcus aureus bacteria, including MRSA strains linked with hospital-acquired infections.

When it is released it triggers an over multiplication of immune cells, which can lead to high fever, toxic shock and potentially fatal lung infections.

The study, published in the journal PLoS Pathogens, will help research to find drugs that could target SElX and prevent damage to healthy cells.

The research, carried out by the Universities of Edinburgh, Iowa and Mississippi State, looked at a strain of MRSA known as USA300 that can cause severe infections in otherwise healthy individuals.

MRSA strains are known to produce different types of toxins but scientists found that SElX is made by virtually all strains of the superbug.

It belongs to a family of toxins known as superantigens, which can invoke an extreme immune response.

Dr Ross Fitzgerald, from The Roslin Institute at the University of Edinburgh, said: "If we can find ways to target this toxin, we can stop it from triggering an over-reaction of the body's immune system and prevent severe infections"

The research was funded by the Biotechnology and Biological Sciences Research Council, the National Institutes of Health, USA, the US Department of Agriculture and Pfizer Animal Health.

Gill Wilson, of The Roslin Institute and first author on the paper, said: "MRSA continues to be a global problem. This research could help us find a new way to target the infection."


Story Source:

The above story is based on materials provided by University of Edinburgh. Note: Materials may be edited for content and length.


Journal Reference:

  1. Gillian J. Wilson, Keun Seok Seo, Robyn A. Cartwright, Timothy Connelley, Olivia N. Chuang-Smith, Joseph A. Merriman, Caitriona M. Guinane, Joo Youn Park, Gregory A. Bohach, Patrick M. Schlievert, W. Ivan Morrison, J. Ross Fitzgerald. A Novel Core Genome-Encoded Superantigen Contributes to Lethality of Community-Associated MRSA Necrotizing Pneumonia. PLoS Pathogens, 2011; 7 (10): e1002271 DOI: 10.1371/journal.ppat.1002271

Cite This Page:

University of Edinburgh. "Study could help battle against superbugs." ScienceDaily. ScienceDaily, 14 October 2011. <www.sciencedaily.com/releases/2011/10/111013184809.htm>.
University of Edinburgh. (2011, October 14). Study could help battle against superbugs. ScienceDaily. Retrieved November 28, 2014 from www.sciencedaily.com/releases/2011/10/111013184809.htm
University of Edinburgh. "Study could help battle against superbugs." ScienceDaily. www.sciencedaily.com/releases/2011/10/111013184809.htm (accessed November 28, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, November 28, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins